Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Taxol administration

C Rutherford

    Journal of Intravenous Nursing : the Official Publication of the Intravenous Nurses Society
    |May 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    New chemotherapy drug Taxol shows effectiveness in treating advanced ovarian cancer, particularly in patients resistant to platinum-based therapies. This offers a new treatment option for women with metastatic disease who have exhausted other options.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The rate of non-sentinel lymph node metastases at axillary dissection in patients with a positive sentinel lymph node after neoadjuvant chemotherapy.

    Surgical oncology·2026
    Same author

    The impact of anal cancer treatment on female sexuality and intimacy: a systematic review.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
    Same author

    Use of superparamagnetic iron oxide for sentinel lymph node detection following neoadjuvant systemic therapy. A systematic review and meta-analysis.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
    Same author

    Invasive lobular carcinoma of the breast; clinicopathologic profile and response to neoadjuvant chemotherapy over a 15-year period.

    Breast (Edinburgh, Scotland)·2024
    Same author

    Breast implant rupture mimicking BIA-ALCL.

    Irish medical journal·2023
    Same author

    'PartBreCon' study. A UK multicentre retrospective cohort study to assess outcomes following PARTial BREast reCONstruction with chest wall perforator flaps.

    Breast (Edinburgh, Scotland)·2023
    Same journal

    The role of the perfusionist.

    Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
    Same journal

    Silicone catheter fracture secondary to stress events and a dressing technique to reduce those events.

    Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
    Same journal

    Fluid resuscitation in acutely injured patients.

    Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
    Same journal

    A story on childhood immunization practices, complete with camera footage of a nurse administering "a shot" to a child without using personal protective equipment.

    Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
    Same journal

    Clinical application of the World Health Organization analgesic ladder.

    Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
    Same journal

    Laboratory sampling. Alternate site perspectives.

    Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
    See all related articles

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Ovarian cancer frequently presents with widespread abdominal metastasis.
    • Chemotherapy response rates for ovarian cancer were historically low before 1970.
    • Cisplatin significantly improved response rates but acquired resistance is a challenge.

    Purpose of the Study:

    • To evaluate the efficacy of Taxol as a treatment for metastatic ovarian cancer.
    • To assess Taxol's effectiveness in patients with platinum-resistant disease.

    Main Methods:

    • Clinical evaluation of Taxol in patients with ovarian cancer.
    • Assessment of treatment response in patients with prior chemotherapy failure.

    Main Results:

    • Taxol demonstrated efficacy in patients with metastatic ovarian cancer.

    Related Experiment Videos

  • The drug was effective even in patients with platinum-resistant disease.

    • Conclusions:

    • Taxol represents a viable therapeutic option for ovarian cancer patients.
    • It provides a new avenue for managing platinum-resistant metastatic ovarian cancer.